There are few data in the literature reporting the evolution of hypogammaglobulinemia in premature and full-term infants during the first years of life. The aim of this study was to assess the clinical and immunological evolution of premature and full-term infants with hypogammaglobulinemia. We included 24 children (11 premature and 13 full-term infants), aged 0-36 months, with hypogammaglobulinemia. Fifteen (62.5%) children had an isolated reduction in IgG, 7 (29.2%) had a decrease in both IgG and IgA and 2 (8.3%) a reduction in IgG and IgM. Normalization of IgG serum levels occurred in the premature infants at a mean age of 7.2 months. FUll-term infants were divided into 3 groups based on age at normalization of IgG serum level: A) hypogammaglobulinemia with normalization within 12 months of life; B) with normalization within 36 months of life; C) normalization after 36 months. All the premature infants with hypogammaglobulinemia recovered, even though in the lower limits for age in the first years, while transient hypogammaglobulinemia observed in full-term infants has a different age of recovery.
Immunoglobulins(Igs) G levels are physiologically lower in the first months of life, a condition that increases in premature infants in direct proportion to gestational age (1-2). In some infants, occasionally, adequate Ig synthesis may be abnormally delayed until 36 months of age, resulting in a prolonged reduction of Ig levels; this process is referred to as transient hypogammaglobulinemia of infancy (THI) (3).At present there are no clinical features or diagnostic tests that differentiate self-limiting hypogammaglobulinemia from permanent immune defects in young children. A definitive diagnosis of THI is only possible a posteriori, after normalization of IgG levels and the exclusion of other causes of hypogammaglobulinemia.The aim ofthis study is to appraise the clinical and immunological features of premature and full-term infants with a diagnosis of hypogammaglob ulinemi a and their subsequent evolution.
MATERIALS AND METHODSThe study included 24 children (aged 0-36 months), consecutively referred to the Department of Pediatrics, Pediatrics Allergology and Immunology Center of Bologna University between January I, 2000 and December 31, 2008, with a diagnosis of hypogammaglobulinemia associated with other clinical symptoms. Hypogammaglobulinemia was considered if the infants showed values of one or more Ig isotypes below the "lower limit" «2 DS) of our pre-determined set of reference ranges per age (4).